Researchers have developed a novel method to deliver nanobodies, which are small antibody fragments, directly inside cells to treat cystic fibrosis. These nanobodies are fused with a cell-penetrating peptide, enabling them to cross the cell membrane and stabilize the misfolded CFTR protein from within. When combined with existing therapies, this approach has shown potential to restore nearly normal protein function in patient-derived cells. AI
Summary written by gemini-2.5-flash-lite from 1 source. How we write summaries →
IMPACT Novel delivery mechanism for protein therapeutics could accelerate development of intracellular treatments for various diseases.
RANK_REASON The cluster describes new research findings on a novel therapeutic approach for a specific disease. [lever_c_demoted from research: ic=1 ai=0.7]
